Chugai Pharm ADR (CHGCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 06-2021 | 03-2021 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | N/A | N/A | N/A | 1,449,552 |
| Depreciation Amortization | N/A | N/A | N/A | N/A | 242,889 |
| Other Working Capital | -285,159 | -117,299 | 377,579 | -320,077 | 57,086 |
| Other Operating Activity | 909,011 | 1,054,617 | 59,906 | 366,160 | 151,570 |
| Operating Cash Flow | $623,853 | $937,318 | $437,485 | $46,083 | $1,901,097 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 23,813 | -343,689 | -141,000 | -43,001 | N/A |
| PPE Investments | -293,888 | -312,476 | -271,923 | -101,927 | -486,588 |
| Purchase Of Investment | -310 | -1,065 | -555 | -322 | N/A |
| Purchase Sale Intangibles | -22,489 | -40,422 | -27,683 | -11,279 | N/A |
| Other Investing Activity | -21,861 | -39,785 | -27,345 | -10,985 | -265,429 |
| Investing Cash Flow | $-292,245 | $-697,015 | $-440,822 | $-156,234 | $-752,017 |
| Cash Flows From Financing Activities | |||||
| Dividend Paid | -646,376 | -448,739 | -461,061 | -460,938 | -518,604 |
| Other Financing Activity | -14,697 | -37,055 | -19,505 | -17,149 | -96,618 |
| Financing Cash Flow | $-661,073 | $-485,794 | $-480,566 | $-478,087 | $-615,222 |
| Exchange Rate Effect | 8,867 | 16,143 | 11,242 | -11,877 | -8,712 |
| Beginning Cash Position | 2,302,676 | 1,932,230 | 1,995,930 | 1,876,257 | 1,351,112 |
| End Cash Position | 1,982,076 | 1,702,892 | 1,523,261 | 1,276,132 | 1,876,257 |
| Net Cash Flow | $-320,599 | $-229,338 | $-472,670 | $-600,116 | $525,145 |
| Free Cash Flow | |||||
| Operating Cash Flow | 623,853 | 937,318 | 437,485 | 46,083 | 1,901,097 |
| Capital Expenditure | -293,423 | -322,358 | -272,111 | -102,028 | N/A |
| Free Cash Flow | 330,429 | 614,960 | 165,374 | -55,945 | 1,901,097 |